Assoc Prof Amit Goyal
Consultant Oncoplastic and Cosmetic Breast Surgeon
MS, MD, FRCS
I have been a consultant oncoplastic breast surgeon for over 10 years, and I am an expert in all aspects of breast diseases and surgery, especially cosmetic and reconstruction breast surgery. I am a Royal College of Surgeons certified Cosmetic Breast Surgeon. I regularly host international visiting fellows who want to further develop their cosmetic and reconstruction breast surgery skills.
I specialise in breast cancer oncoplastic and reconstructive surgery and all cosmetic breast surgery.
I have been awarded around £6 million grant funding by NIHR HTA for breast cancer research. I lead the largest breast cancer surgical research trials in the UK – POSNOC and ATNEC. I am the Oncology and Breast Specialty Editor of the Surgery journal (UK). I am the breast research lead for East Midlands. I am the Chief Investigator of the BIOSYM randomised breast reconstruction trial that compares synthetic with biological matrices.
I received the 2012 NHS Innovation Award (Health Enterprise East) for developing DigiBreast3D – a low-cost 3D surface imaging system in reconstructive and cosmetic breast surgery. I was the co-recipient of the NHS Cancer Innovation Award 2007 for introducing intra-operative sentinel node assessment to reduce the number of second operations for patients needing axillary node clearance.
I have presented work at different meetings and am the author or co-author of more than 80 peer-reviewed papers and book chapters on breast diseases.
Some of the principal treatments carried out by Assoc Prof Amit Goyal at Spire include:
Breast care and surgery
COVID-19 testing or antibody tests are not available as a standalone service at Spire Nottingham Hospital.
FRCS / Royal College of Physicians and Surgeons of Glasgow / 2001
MD / Cardiff University / 2008
Bachelor of Medicine/Bachelor of Surgery
Breast Cancer research
I am the CRN Breast lead, and ECAG Breast Audit & Research lead for East Midlands, I am the Oncology Specialty Editor of the Surgery journal. I lead the national TiLOOP reconstruction audit.
I am the Chief Investigator of the UK-ANZ breast cancer POSNOC trial.